Medication

Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist used for weight loss and glycemic control.

Tirzepatide is a dual-agonist medication targeting both GIP and GLP-1 receptors. Administered weekly by subcutaneous injection, it supports weight loss and metabolic regulation. Prescribed at REVRCEL in compounded form under physician oversight.

Related terms

GLP-1 (Glucagon-Like Peptide-1)Semaglutide

Statements have not been evaluated by the FDA. Educational content only; not medical advice.